Trends in the commercial development of antibody therapeutics: The early-stage clinical pipeline
25:33
Trends in the early-stage clinical development of antibody therapeutics
1:09:35
Antibodies to watch in 2024
58:54
Optimizing Oxidation in the Care of Chronically Ill Patients
1:08:53
Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More
27:51
Antibody validation for reproducible flow cytometry analysis [WEBINAR]
19:52
Dentro del cañón V3 London
59:55
NATURE AND BEYOND: Fc Mediated Enhancement of Anti-Viral Antibodies - Jon Yewdell, M.D., Ph.D.
1:37:34